1. Home
  2. CTSO vs MOBX Comparison

CTSO vs MOBX Comparison

Compare CTSO & MOBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • MOBX
  • Stock Information
  • Founded
  • CTSO 1997
  • MOBX 2020
  • Country
  • CTSO United States
  • MOBX United States
  • Employees
  • CTSO N/A
  • MOBX N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • MOBX
  • Sector
  • CTSO Health Care
  • MOBX
  • Exchange
  • CTSO Nasdaq
  • MOBX Nasdaq
  • Market Cap
  • CTSO 58.6M
  • MOBX 52.0M
  • IPO Year
  • CTSO N/A
  • MOBX N/A
  • Fundamental
  • Price
  • CTSO $0.85
  • MOBX $0.83
  • Analyst Decision
  • CTSO Buy
  • MOBX
  • Analyst Count
  • CTSO 2
  • MOBX 0
  • Target Price
  • CTSO $5.50
  • MOBX N/A
  • AVG Volume (30 Days)
  • CTSO 66.2K
  • MOBX 2.2M
  • Earning Date
  • CTSO 11-06-2025
  • MOBX 08-13-2025
  • Dividend Yield
  • CTSO N/A
  • MOBX N/A
  • EPS Growth
  • CTSO N/A
  • MOBX N/A
  • EPS
  • CTSO N/A
  • MOBX N/A
  • Revenue
  • CTSO $36,107,520.00
  • MOBX $10,984,000.00
  • Revenue This Year
  • CTSO $11.93
  • MOBX N/A
  • Revenue Next Year
  • CTSO $21.22
  • MOBX N/A
  • P/E Ratio
  • CTSO N/A
  • MOBX N/A
  • Revenue Growth
  • CTSO 20.18
  • MOBX 180.13
  • 52 Week Low
  • CTSO $0.71
  • MOBX $0.55
  • 52 Week High
  • CTSO $1.61
  • MOBX $2.47
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 39.19
  • MOBX 45.45
  • Support Level
  • CTSO $0.80
  • MOBX $0.75
  • Resistance Level
  • CTSO $0.86
  • MOBX $0.83
  • Average True Range (ATR)
  • CTSO 0.04
  • MOBX 0.08
  • MACD
  • CTSO -0.01
  • MOBX -0.01
  • Stochastic Oscillator
  • CTSO 24.74
  • MOBX 19.32

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About MOBX Mobix Labs Inc.

Mobix Labs Inc. specializes in designing, developing, and selling components and systems for wireless and wired connectivity, radio frequency (RF) technologies, switching, and electromagnetic interference (EMI) filtering solutions. The company serves markets, including commercial, industrial, automotive, medical, aerospace, defense, and others.

Share on Social Networks: